Sean Tucker
Founder at VAXART, INC.
Net worth: 193 029 $ as of 2024-05-30
Network origin in Sean Tucker first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
32
| Public Company | Biotechnology | 32 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Sean Tucker via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | President Corporate Officer/Principal Corporate Officer/Principal | |
| NOVAVAX, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| TENAX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Corporate Officer/Principal | |
AcuFocus, Inc.
 AcuFocus, Inc. Medical SpecialtiesHealth Technology AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| KIORA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Vivaldi Biosciences, Inc.
 Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO. | Drugstore Chains | Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree Masters Business Admin | |
| University of Pennsylvania | College/University | Corporate Officer/Principal | |
Care Capital LLC
 Care Capital LLC Investment ManagersFinance Care Capital LLC (care capital) is a venture capital firm founded in 2001 by Jan Leschly and David Ramsay. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Founder Private Equity Investor | |
| Emory University | College/University | Graduate Degree | |
| Golden Gate University | College/University | Masters Business Admin Masters Business Admin | |
| The University of Chicago | College/University | Doctorate Degree | |
| Purdue University | College/University | Undergraduate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Davis | College/University | Graduate Degree Undergraduate Degree | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Amsterdam | College/University | Doctorate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Trinity Biosystems, Inc.
 Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Harvard Business School Health Industry Alumni Association | Director/Board Member | ||
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin | |
| Harvard Business School | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
QUE Oncology, Inc.
 QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology QUE Oncology, Inc. engages in preventing and treating life-threatening cancers such as prostate cancer, breast cancer, melanoma, and cancer pain; and related conditions. The company is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
seqWell, Inc.
 seqWell, Inc. BiotechnologyHealth Technology seqWell, Inc. operates as biotechnology company. Its products include plexWellTM 96, plexWellTM 384, plexWellTM Plus 24, and plexWell LP 384. The company was founded by Joseph Mellor and is headquartered in Beverly, MA. | Biotechnology | Director/Board Member | |
Driver Bioengineering, Inc.
 Driver Bioengineering, Inc. Medical SpecialtiesHealth Technology Driver Bioengineering, Inc. develops modular, drug-responsive, titratable, ribozyme based control devices for chimeric antigen receptor. It engages in building control systems for chimeric antigen receptor (CAR) T-cell therapeutics. The company was founded by Gusti Zeiner, Christina Smolke and Benjamin Wang on May 12, 2015 and is headquartered in Menlo Park, CA. | Medical Specialties | Director/Board Member | |
Palvella Therapeutics, Inc.
 Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | Biotechnology | Director/Board Member Director/Board Member | |
Royaltyrx Capital LLC
 Royaltyrx Capital LLC Financial ConglomeratesFinance Royaltyrx Capital LLC provides investment services in the pharmaceutical industry. The American company was founded by Todd C. Davis. | Financial Conglomerates | Founder | |
KarnaTeq, Inc.
 KarnaTeq, Inc. Medical/Nursing ServicesHealth Services KaRNATeq, Inc. develops tools for RNA sequencing in genomics. The company is headquartered in Berkeley, CA. | Medical/Nursing Services | Director/Board Member | |
S2 Genomics, Inc.
 S2 Genomics, Inc. BiotechnologyHealth Technology S2 Genomics, Inc. develops laboratory automation solutions for processing solid tissues for life science applications. The company was founded by Stevan Jovanovich, Peter Wagner, Shannon Hall and Roger McIntosh in 2016 and is headquartered in Livermore, CA. | Biotechnology | Director/Board Member | |
Benuvia Therapeutics, Inc.
 Benuvia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Benuvia Therapeutics, Inc. engages in pharmaceutical and therapeutic drug development services. The company is headquartered in Chandler, AZ. | Pharmaceuticals: Major | Chief Executive Officer | |
Virocell Biologics Ltd.
 Virocell Biologics Ltd. BiotechnologyHealth Technology Virocell Biologics Ltd. is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials. The company is based in London, UK. The British company leverages its expertise in vector manufacture directly into the production of gene-modified cells, both adherent cells such as Mesenchymal Stromal/Stem cells and suspension cultures such as CAR T-cells. Virocell Biologics is committed to leveraging its deep experience to rapidly design and select a manufacturing strategy best suited to the client's objectives. The company was founded by Farzin Farzaneh, John W. Hadden. John W. Hadden has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
| CHROMOCELL THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Chairman |
Statistics
International
| United States | 46 |
| United Kingdom | 3 |
| Netherlands | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 13 |
| Finance | 3 |
| Retail Trade | 2 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 173 |
| Corporate Officer/Principal | 92 |
| Independent Dir/Board Member | 60 |
| Director of Finance/CFO | 30 |
| Chairman | 30 |
Most connected contacts
| Insiders | |
|---|---|
| Julie Cherrington | 32 |
| Karen Wilson | 31 |
| John P. Richard | 24 |
| David Wheadon | 23 |
| Anne VanLent | 23 |
| Elaine Heron | 23 |
| Todd Davis | 23 |
| Geoffrey F. Cox | 20 |
| Michael Finney | 19 |
| William Watson | 19 |
| Illya Keith Maher | 17 |
| Richard Markham | 17 |
| David N. Taylor | 16 |
| Jan Leschly | 16 |
| Robert Yedid | 12 |
- Stock Market
- Insiders
- Sean Tucker
- Company connections
